Eris Lifesciences has issued a clarification regarding a news article that misrepresented the company’s loan status. The company stated that the correct value of the loan availed is as per the disclosure already made by the company. Investors are advised to rely on information disseminated by the exchanges for investment decisions.
Clarification on News Article
Eris Lifesciences Limited has issued a subject: CLARIFICATION ON NEWS ARTICLE PURSUANT TO REGULATION 30 OF THE SEBI (LODR) REGULATIONS, 2015. This clarification addresses publications from InvestyWise News, dealroom.co, and others dated 9th September 2026.
Loan Disclosure Reaffirmed
The company emphasizes that the correct value of the loan availed by Eris Lifesciences is accurately reflected in the disclosures already made. Readers are strongly advised to refer to and rely on the official information disseminated by the stock exchanges before making any investment-related decisions concerning the company’s securities.
Source: BSE
